Back to Agenda
SESSION 7: INTERFACE WITH COMMERCIAL AND LEGAL GROUPS
Session Chair(s)
Shelley Gandhi, MSc
Strategic Advisor, Pharmacovigilance and Drug Safety
NDA Group, United Kingdom
This session will cover best practices about liaising with commercial teams concerning investigator-initiated research, market research and patient support programmes. In addition, relationships with legal group is important concerning agreements with partners to ensure adequate pharmacovigilance obligations are in place and that the QPPV is consulted early when future partnerships or product acquisitions are planned.
Speaker(s)
INTERFACE WITH COMMERCIAL AND LEGAL GROUPS
Shelley Gandhi, MSc
NDA Group, United Kingdom
Strategic Advisor, Pharmacovigilance and Drug Safety
Have an account?